Chairwoman Maloney Applauds Biden-Harris Administration’s 2022 National Drug Control Strategy, Announces Hearing with ONDCP Director Rahul Gupta
Washington, D.C. (April 21, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement regarding the White House Office of National Drug Control Policy’s 2022 National Drug Control Strategy:
“The 2022 National Drug Control Strategy reflects the Biden-Harris Administration’s deep commitment to overcoming our nation’s overdose crisis and ensuring that every person who experiences addiction can achieve and sustain recovery.
I applaud the Office of National Drug Control Policy for its work to expand access to high-quality treatment and harm reduction services, disrupt the flow of dangerous substances into the United States, and advance equity in the federal government’s response to overdose and addiction. I look forward to hearing directly from Director Gupta about the National Drug Control Strategy and the Administration’s progress in overcoming this public health crisis.”